Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Concentration of Endogenous Secretory Receptor for Advanced Glycation End Products and Matrix Gla Protein in Controlled and Uncontrolled Type 2 Diabetes Mellitus Patients

The Indonesian Biomedical Journal · Vol. 5 No. 1 (2013) · hlm. 31–31

DOI
10.18585/inabj.v5i1.48
ISSN
2085-3297, 2355-9179
Terbit
2013-04-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Advanced glycation end products (AGE) and their receptor (RAGE) system play an important role in the development of diabetic vascular complications. Recently, an endogenous secretory RAGE (esRAGE) has been identified as a novel splice variant, which lacks the transmembrane domain and is secreted in human sera. Interestingly, it was reported that esRAGE binds AGE ligands and neutralizes AGE actions. Many studies have reported that diabetes mellitus correlates with vascular calcification event and increases progressively in uncontrolled diabetes. Matrix Gla Protein (MGP) is known to act as an inhibitor in vascular calcification. The aim of this study was to observe progress of vascular calcification in uncontrolled diabetes patient by biochemical markers MGP as inhibitor in vascular calcification, via mechanism of AGEs.METHODS: This study was an observational study with cross sectional design on adult type 2 diabetic male patients who were defined by the 2011 Indonesian diabetes mellitus consensus criteria.RESULTS: The results of this study showed that there was a positive significant correlation between esRAGE and HbA1C (r=0.651, p=0.009), and negative correlation between MGP and HbA1C (r=-0.465, p=0.081) in controlled diabetes group. In uncontrolled diabetes group there was a positive significant correlation between MGP and HbA1C (r=0.350, p=0.023), despite the fact esRAGE showed no significant correlation with HbA1C. There was no significant difference in level of esRAGE and MGP in controlled and uncontrolled diabetes group, but MGP showed lower level in uncontrolled diabetes group, contrary to esRAGE that had higher concentration.CONCLUSION: In diabetes condition, complications of vascular calcification are caused by the mechanism of increased AGE formation represented by esRAGE. In diabetes control it is very important to keep the blood vessels from complications caused by vascular calcification.KEYWORDS: type 2 diabetes mellitus, vascular calcification, esRAGE, MGP, HbA1C

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 149 tautan kepenulisan bersama · 44 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Hasanuddin University
  • Diponegoro University
  • Padjadjaran University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Udayana University
  • University of Indonesia
  • Universitas Airlangga
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anna MeilianaPadjadjaran University89
Nurrani Mustika DewiPadjadjaran University45
Gatot Susilo LawrenceHasanuddin University9
Yani LinaHasanuddin University8
Cynthia Retna SartikaPT Prodia StemCell Indonesia (Indonesia)6
Ilhamjaya PatellongiHasanuddin University5
Teguh RanakusumaUniversity of Indonesia5
Anwar SantosoUdayana University4
Syakib BakriHasanuddin University4
Yenny SurjawanHasanuddin University4
Agussalim BukhariHasanuddin University3
Andi Yasmin SyaukiHasanuddin University3
Nurbaya SyamHasanuddin University3
Irawan YusufHasanuddin University3
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)3
Trilis YuliantiHasanuddin University3
Marsetio DonosepoetroUniversitas Airlangga3
Citra KesumasariHasanuddin University2
AminuddinHasanuddin University2
Mardiana MadjidHasanuddin University2
Nur ASHARIHasanuddin University2
Nur Ainun RaniHasanuddin University2
Andi FaradilahHasanuddin University2
A Arsyi A P SADIKINHasanuddin University2
Rizky Suganda PrawiradilagaBandung Islamic University2
Nurpudji Astuti TaslimHasanuddin University2
Burhanuddin BaharHasanuddin University2
Zakaria ZakariaIPB University2
Veni HadjuHasanuddin University2
Ari YuniastutiState University of Semarang2
Sri Achadi NugraheniDiponegoro University2
Pingkan FristiwiDiponegoro University2
Fatimah Asri Fadhilah AuliaDiponegoro University2
Shafa Alya KamilaDiponegoro University2
Irfan IdrisHasanuddin University2
Hamsu KadriyanUniversity of Mataram2

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Concentration of Endogenous Secretory Receptor for Advanced Glycation End Products and Matrix Gla Protein in Controlled and Uncontrolled Type 2 Diabetes Mellitus Patients</dc:title><dc:creator>Dwi Yuniati Daulay</dc:creator><dc:creator>Suryani As’ád</dc:creator><dc:creator>Ali Aspar Mappahya</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:subject>type 2 diabetes</dc:subject><dc:subject>vascular calcification</dc:subject><dc:subject>advanced glycation end products</dc:subject><dc:subject>RAGE</dc:subject><dc:subject>matrix Gla protein</dc:subject><dc:subject>glycemic control</dc:subject><dc:subject>HbA1c</dc:subject><dc:subject>diabetic vascular complications</dc:subject><dc:description xml:lang="en">BACKGROUND: Advanced glycation end products (AGE) and their receptor (RAGE) system play an important role in the development of diabetic vascular complications. Recently, an endogenous secretory RAGE (esRAGE) has been identified as a novel splice variant, which lacks the transmembrane domain and is secreted in human sera. Interestingly, it was reported that esRAGE binds AGE ligands and neutralizes AGE actions. Many studies have reported that diabetes mellitus correlates with vascular calcification event and increases progressively in uncontrolled diabetes. Matrix Gla Protein (MGP) is known to act as an inhibitor in vascular calcification. The aim of this study was to observe progress of vascular calcification in uncontrolled diabetes patient by biochemical markers MGP as inhibitor in vascular calcification, via mechanism of AGEs.METHODS: This study was an observational study with cross sectional design on adult type 2 diabetic male patients who were defined by the 2011 Indonesian diabetes mellitus consensus criteria.RESULTS: The results of this study showed that there was a positive significant correlation between esRAGE and HbA1C (r=0.651, p=0.009), and negative correlation between MGP and HbA1C (r=-0.465, p=0.081) in controlled diabetes group. In uncontrolled diabetes group there was a positive significant correlation between MGP and HbA1C (r=0.350, p=0.023), despite the fact esRAGE showed no significant correlation with HbA1C. There was no significant difference in level of esRAGE and MGP in controlled and uncontrolled diabetes group, but MGP showed lower level in uncontrolled diabetes group, contrary to esRAGE that had higher concentration.CONCLUSION: In diabetes condition, complications of vascular calcification are caused by the mechanism of increased AGE formation represented by esRAGE. In diabetes control it is very important to keep the blood vessels from complications caused by vascular calcification.KEYWORDS: type 2 diabetes mellitus, vascular calcification, esRAGE, MGP, HbA1C</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2013-04-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v5i1.48</dc:identifier><dc:identifier>10.18585/inabj.v5i1.48</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 5 No 1 (2013); 31-31</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/48/214</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>